ERVIN GRAVES STRATEGY GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Homeland Security HOM
FY17 and FY18 Appropriations- provisions related to development, acquisition, and stockpiling of medical countermeasures Provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES L ERVIN | Chairman & CEO |
| COLBY MILLER New | — |
| DEVIN SEARS | Managing Associate |
Disaster Planning/Emergencies DIS
FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES L ERVIN | Chairman & CEO |
| COLBY MILLER New | — |
| DEVIN SEARS | — |
Budget/Appropriations BUD
FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES L ERVIN | Chairman & CEO |
| COLBY MILLER New | — |
| DEVIN SEARS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.